OTCMKTS:RHHBY - Roche Holdings AG Basel ADR Common Stock Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$28.91 -0.33 (-1.13 %)
(As of 07/19/2018 04:00 PM ET)
Previous Close$29.24
Today's Range$28.77 - $29.03
52-Week Range$26.30 - $32.42
Volume2.82 million shs
Average Volume1.22 million shs
Market Capitalization$198.06 billion
P/E Ratio14.83
Dividend Yield3.07%
Beta0.53
Roche Holdings AG Basel ADR Common Stock logoRoche Holding AG diagnostics and pharmaceuticals businesses in Switzerland, Germany, and rest of Europe. It offers pharmaceutical products for anaemia, anticoagulation therapy, bone, cancer, cardiovascular, central nervous system, chlamydia, coagulation, dermatology, diabetes, gonorrhea, gout, hemostasis disorders, hepatitis B and C, HIV/AIDS, HPV, infectious diseases, inflammatory and autoimmune, intensive care medicine, kidney and urogenital tract, leukemia, lipid disorders, liver, lymphoma, metabolic disorders, obesity, occult blood testing, ophthalmology, osteoporosis, pancreatitis, respiratory disorders, rheumatoid arthritis, sepsis, sexually transmitted infections, skin cancer, transplantation, tuberculosis, urinary tract infections, and West Nile virus diseases. The company provides diagnostic solutions, such as blood gas analysis; blood screening; cancer screening/monitoring; cardiac markers; cardiovascular testing; cholesterol monitoring; coagulation monitoring; coagulation routine and specialty testing; data management; diabetes monitoring; diabetes therapy; electrolytes analysis; emergency medicine; hemostasis; heterogeneous immunochemistry; homogeneous immuno assays; immunology; infectious diseases; intensive care testing; monitoring anti platelet therapy; neonatal intensive care units; nucleic acid purification; PCR clinical diagnostics; physical fitness testing; platelet function testing; quality control service; real-time PCR diagnostic systems; serum work area; urinalysis; and workflow solutions. Roche Holding AG has a strategic alliance with Wisconsin Diagnostic Laboratories; and a collaboration agreement with Five Prime Therapeutics, Inc. The company was founded in 1896 and is headquartered in Basel, Switzerland.

Receive RHHBY News and Ratings via Email

Sign-up to receive the latest news and ratings for RHHBY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Private households
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:RHHBY
CUSIPN/A
Phone41-61-688-1111

Debt

Debt-to-Equity Ratio0.55
Current Ratio1.42
Quick Ratio1.09

Price-To-Earnings

Trailing P/E Ratio14.83
Forward P/E Ratio13.77
P/E Growth2.02

Sales & Book Value

Annual Sales$54.15 billion
Price / Sales3.64
Cash Flow$2.5337 per share
Price / Cash11.41
Book Value$4.33 per share
Price / Book6.68

Profitability

EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A

Miscellaneous

Employees94,052
Outstanding Shares6,815,420,000
Market Cap$198,055.98

Roche Holdings AG Basel ADR Common Stock (OTCMKTS:RHHBY) Frequently Asked Questions

What is Roche Holdings AG Basel ADR Common Stock's stock symbol?

Roche Holdings AG Basel ADR Common Stock trades on the OTCMKTS under the ticker symbol "RHHBY."

What price target have analysts set for RHHBY?

10 analysts have issued twelve-month price objectives for Roche Holdings AG Basel ADR Common Stock's shares. Their forecasts range from $38.00 to $38.00. On average, they anticipate Roche Holdings AG Basel ADR Common Stock's stock price to reach $38.00 in the next twelve months. This suggests a possible upside of 31.4% from the stock's current price. View Analyst Ratings for Roche Holdings AG Basel ADR Common Stock.

What is the consensus analysts' recommendation for Roche Holdings AG Basel ADR Common Stock?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Roche Holdings AG Basel ADR Common Stock in the last year. There are currently 4 sell ratings, 3 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold."

Who are some of Roche Holdings AG Basel ADR Common Stock's key competitors?

Who are Roche Holdings AG Basel ADR Common Stock's key executives?

Roche Holdings AG Basel ADR Common Stock's management team includes the folowing people:
  • Ms. Cristina A. Wilbur, Head of Group HR (Age 51)
  • Dr. Severin Schwan, CEO & Exec. Director (Age 51)
  • Dr. Alan Hippe, Chief Financial & IT Officer (Age 51)
  • Dr. Gottlieb A. Keller, Gen. Counsel & Corp. Sec. (Age 64)
  • Dr. Urs Jaisli, Chief Compliance Officer (Age 62)

Has Roche Holdings AG Basel ADR Common Stock been receiving favorable news coverage?

Media headlines about RHHBY stock have been trending somewhat positive on Thursday, Accern Sentiment reports. The research firm ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. Roche Holdings AG Basel ADR Common Stock earned a news impact score of 0.09 on Accern's scale. They also assigned news coverage about the company an impact score of 47.64 out of 100, meaning that recent press coverage is somewhat unlikely to have an effect on the company's share price in the immediate future.

Who are Roche Holdings AG Basel ADR Common Stock's major shareholders?

Roche Holdings AG Basel ADR Common Stock's stock is owned by a number of of institutional and retail investors. Top institutional investors include Fisher Asset Management LLC (0.25%), Riverbridge Partners LLC (0.01%), Patten & Patten Inc. TN (0.00%), Kempner Capital Management Inc. (0.00%), Scout Investments Inc. (0.00%) and Jolley Asset Management LLC (0.00%). View Institutional Ownership Trends for Roche Holdings AG Basel ADR Common Stock.

Which major investors are selling Roche Holdings AG Basel ADR Common Stock stock?

RHHBY stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Patten & Patten Inc. TN, New England Research & Management Inc., Jacobs & Co. CA, Bath Savings Trust Co and Capital One National Association. View Insider Buying and Selling for Roche Holdings AG Basel ADR Common Stock.

Which major investors are buying Roche Holdings AG Basel ADR Common Stock stock?

RHHBY stock was purchased by a variety of institutional investors in the last quarter, including Fisher Asset Management LLC, Jolley Asset Management LLC, Kempner Capital Management Inc. and Scout Investments Inc.. View Insider Buying and Selling for Roche Holdings AG Basel ADR Common Stock.

How do I buy shares of Roche Holdings AG Basel ADR Common Stock?

Shares of RHHBY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Roche Holdings AG Basel ADR Common Stock's stock price today?

One share of RHHBY stock can currently be purchased for approximately $28.91.

How big of a company is Roche Holdings AG Basel ADR Common Stock?

Roche Holdings AG Basel ADR Common Stock has a market capitalization of $198.06 billion and generates $54.15 billion in revenue each year. The company earns $8.77 billion in net income (profit) each year or $1.95 on an earnings per share basis. Roche Holdings AG Basel ADR Common Stock employs 94,052 workers across the globe.

How can I contact Roche Holdings AG Basel ADR Common Stock?

Roche Holdings AG Basel ADR Common Stock's mailing address is GRENZACHERSTRASSE 124, BASEL V8, CH-4070. The company can be reached via phone at 41-61-688-1111 or via email at [email protected]


MarketBeat Community Rating for Roche Holdings AG Basel ADR Common Stock (OTCMKTS RHHBY)

Community Ranking:  2.4 out of 5 (star star)
Outperform Votes:  132 (Vote Outperform)
Underperform Votes:  145 (Vote Underperform)
Total Votes:  277
MarketBeat's community ratings are surveys of what our community members think about Roche Holdings AG Basel ADR Common Stock and other stocks. Vote "Outperform" if you believe RHHBY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RHHBY will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 7/19/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.